Literature DB >> 19420686

Hyperproduction of 3,4-dihydroxyphenyl-L-alanine (L-Dopa) using Erwinia herbicola cells carrying a mutant transcriptional regulator TyrR.

Takashi Koyanagi1, Takane Katayama, Hideyuki Suzuki, Akiko Onishi, Kenzo Yokozeki, Hidehiko Kumagai.   

Abstract

In the last few decades, enzymatic production of 3,4-dihydroxyphenyl-L-alanine (L-dopa) using tyrosine phenol-lyase (Tpl) has been industrialized. This method has an intrinsic problem of tyrosine contamination because Tpl is synthesized under tyrosine-induced conditions. Herein, we constructed a hyper-L-dopa-producing strain by exploiting a mutant TyrR, an activator of tpl. The highest productivity was obtained for the strain grown under non-induced conditions. It was 30-fold higher than that obtained for tyrosine-induced wild-type cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19420686     DOI: 10.1271/bbb.90019

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

1.  Integrating enzyme evolution and high-throughput screening for efficient biosynthesis of L-DOPA.

Authors:  Weizhu Zeng; Bingbing Xu; Guocheng Du; Jian Chen; Jingwen Zhou
Journal:  J Ind Microbiol Biotechnol       Date:  2019-09-18       Impact factor: 3.346

2.  Efficient strategies to enhance plasmid stability for fermentation of recombinant Escherichia coli harboring tyrosine phenol lyase.

Authors:  Xiao-Ling Tang; Wen-Ye Hu; Zhi-Chao Wang; Ren-Chao Zheng; Yu-Guo Zheng
Journal:  Biotechnol Lett       Date:  2021-04-08       Impact factor: 2.461

Review 3.  Microbial production of isoquinoline alkaloids as plant secondary metabolites based on metabolic engineering research.

Authors:  Fumihiko Sato; Hidehiko Kumagai
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

4.  The expression of stlA in Photorhabdus luminescens is controlled by nutrient limitation.

Authors:  Lea Lango-Scholey; Alexander O Brachmann; Helge B Bode; David J Clarke
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.